Free Access
Vet. Res.
Volume 31, Number 5, September-October 2000
Page(s) 507 - 515
How to cite this article Vet. Res. (2000) 507-515


Billinghurst R.C., Fretz P.B., Gordon J.R., Induction of intra-articular tumor necrosis factor during acute inflammatory responses in equine arthritis, Equine Vet. J. 27 (1995) 208-216.
Bradford M., A rapid and sensitive method for the quantitation of microgram quantities of protein utilising the principle of protein-dye binding, Anal. Biochem. 72 (1976) 248-254.
Brama P.A., Tekoppele J.M., Beeckman B., van Weeren P.R., Barneveld A., Matrix metalloproteinase activity in equine synovial fluid: influence of age, osteoarthritis, and osteochondrosis, Ann. Rheum. Dis. 57 (1998) 697-699.
Birkedal-Hansen H., Moore W.G.I., Bodden M.K., Windsor L.J., Birkedal-Hansen B., Decarlo A., Engler J.A., Matrix metalloproteinases: a review, Crit. Rev. Oral Biol. Med. 4 (1993) 197-250.
Cao J., Sato H., Takino T., Seiki M., The C-terminal region of membrane type matrix metalloproteinase is a functional transmembrane domain required for pro-gelatinase A activation, J. Biol. Chem. 270 (1995) 801-805.
Cawston T.E., Proteinases and inhibitors, Br. Med. Bull. 51 (1995) 385-401.
Clegg P.D., Carter S.D., Matrix metalloproteinase-2 and -9 are activated in joint diseases, Equine Vet. J. 31 (1999) 324-330.
Clegg P.D., Burke R.M., Coughlan A.R., Riggs C.M., Carter S.D., Characterisation of equine matrix metalloproteinase 2 and 9, and identification of the cellular sources of these enzymes in joints, Equine Vet. J. 29 (1997) 335-342.
Clegg P.D., Coughlan A.R., Riggs C.M., Carter S.D., Matrix metalloproteinases 2 and 9 in equine synovial fluids, Equine Vet. J. 29 (1997) 343-348.
Clegg P.D., Coughlan A.R., Carter S.D., Equine TIMP-1 and TIMP-2: Identification, activity and cellular sources, Equine Vet. J. 30 (1998) 416-423.
Gaudin P., Razakaboay M., Surla A., Berthier S., Fauconnier J., Morel F., Phelip X., A study of metalloproteinases in fifty joint fluid specimens, Rev. Rhum. Engl. Ed. 64 (1997) 375-381.
Itoh Y., Binner S., Nagase H., Steps involved in activation of the complex of pro-matrix metalloproteinase 2 (progelatinase A) and TIMP2 by 4-APMA, Biochem. J. 308 (1995) 645-651.
Ishiguro N., Ito T., Miyazaki K., Iwata H., Matrix metalloproteinases, tissue inhibitors of metalloproteinases, and glycosaminoglycans in synovial fluid from patients with rheumatoid arthritis, J. Rheumatol. 26 (1999) 34-40.
Johnson P.J., Tyagi S.C., Katwa L.C., Ganjam V.K., Moore L.A., Kreeger J.M., Messer N.T., Activation of extracellular matrix metalloproteinases in equine laminitis, Vet. Rec. 142 (1998) 392-396.
Mackay R.J., Merritt A.M., Zertuche J.M., Whittington M., Skelley L.A., Tumor necrosis factor activity in the circulation of horses given endotoxin, Am. J. Vet. Res. 52 (1991) 533-538.
McIlwraith C.W., General pathobiology of the joint and response to injury, in Joint Disease in the Horse, Saunders Ed. (1996) 40-70.
Spiers S., May S.A., Bennett D., Edwards G.B., Cellular sources of proteolytic enzymes in equine joints, Equine Vet. J. 26 (1994) 43-47.
Todhunter P.G., Kincaid S.A., Todhunter R.J., Kammermann J.R., Johnstone B., Baird A.N., Hanson R.R., Wright J.M., Lin H.C., Purohit R.C., Immunohistochemical analysis of an equine model of synovitis-induced arthritis, Am. J. Vet. Res. 57 (1996) 1080-1093.
Woessner J.F., Matrix metalloproteinases and their inhibitors in connective tissue remodeling, Fed. Amer. Soc. Exp. Biol. J. 5 (1991) 2145-2154.


Copyright INRA, EDP Sciences